Do corticosteroids affect lumbar spinal fusion? A rabbit model using high-dose methylprednisolone

Area of Science:

• Orthopedic Surgery
• Pharmacology
• Regenerative Medicine

Background:

• The impact of corticosteroids on spinal fusion healing remains unclear.
• High-dose methylprednisolone sodium succinate is frequently used in spinal cord injury patients undergoing fusion.
• This study investigates corticosteroid effects on lumbar spinal fusion.

Purpose of the Study:

• To evaluate the effect of high-dose methylprednisolone sodium succinate on lumbar spinal fusion.
• To determine if corticosteroids impede spinal fusion healing.

Main Methods:

• A randomized, placebo-controlled animal study was conducted.
• Rabbits underwent postero-lateral lumbar fusion (L5-L6) with autologous bone graft.
• Animals received either methylprednisolone sodium succinate or saline, with fusion assessed at 8 weeks via palpation and radiography.

Main Results:

• Fusion was achieved in 27.8% of rabbits treated with methylprednisolone sodium succinate.
• Fusion occurred in 50% of control animals receiving saline.
• The difference in fusion rates between groups was not statistically significant (p=0.17).

Conclusions:

• High-dose methylprednisolone sodium succinate administration appeared to reduce lumbar fusion success in a rabbit model.
• The observed reduction in fusion rates did not reach statistical significance.
• Further research may be needed to clarify the clinical implications of corticosteroid use on spinal fusion.